Valeant smashes earnings, Elon Musk bets big on Tesla, C-Suite shake-up at Snap

Here’s a look at some of the companies the Yahoo Finance team is watching for you.

Pharmaceutical giant Valeant (VRX) smashed adjusted earnings and adjusted net income expectations for its first quarter. The company’s CEO credited the boost to major growth in its Branded RX and Bausch and Lomb. The company is also changing its name to Bausch Health Companies in July.

Elon Musk is betting big on his own company. The Tesla (TSLA) CEO bought about $9.8M dollars worth of Tesla shares.  Musk now owns nearly 20% of his cash-burning electric car company. The move comes after he went after Tesla short-sellers, telling them the “sheer magnitude of short carnage will be unreal.”

There’s a C-Suite shake-up at Snap (SNAP). Chief Financial Officer Andrew Vollero is leaving the company. Both Snap and Vollero agreed on the departure. Vollero will be replaced by Amazon (AMZN) VP of finance Tim Stone on May 16.

AMC’s (AMC) earnings might have actually left some heads spinning just as CEO Adam Aron promised. The theater chain beat big on earnings and revenue expectations for its first quarter. Aron partly attributed the beat to better screens, signature recliner seats, and concession offerings. He added that he can’t wait to see the success of the recent Avengers movie next quarter.

Scroll to continue with content

What to Read Next